Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Business Officer

10 Apr 2018 07:00

RNS Number : 3190K
Collagen Solutions PLC
10 April 2018
 

10 April 2018

 

Collagen Solutions plc

("Collagen Solutions" or the "Company")

 

Appointment of Chief Business Officer

 

Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials for the enhancement and extension of human life, announces the appointment of Louis T. Ruggiero ("Lou") as Chief Business Officer effective as of 16 April 2018.

 

Collagen Solutions recently completed a comprehensive business review with the help of Mr. Ruggiero, including a review of the Company's commercial operations and organisation. During this process, Mr. Ruggiero developed a solid understanding of the Company's opportunity for growth and path to execution, as well as the confidence of the executive team and Board as a strong commercial leader.

 

Mr. Ruggiero is a performance-driven executive with proven success at all levels of sales and general management in the health care and technology industries. He joins Collagen Solutions from Pearson Clinical Assessments where he served as Senior Vice President of Sales. Previously, Mr. Ruggiero spent 10 years as a senior executive and Board Director in the orthopedic device industry. Under his leadership as Chief Commercial Officer of Hely & Weber Orthopedics and Ossur Americas, the companies posted consistent double-digit revenue growth. As the Chief Sales & Marketing Officer of DJO Global, revenue and share price increased over five-fold. Earlier in his career, Mr. Ruggiero served as CEO of Titan Scan Technologies, an early stage B2B company focused on medical device sterilisation and bio-agent remediation. In addition, Mr. Ruggiero served in various leadership roles of increasing responsibility with GE Healthcare, where he earned his Six Sigma Certification.

 

Mr. Ruggiero is a summa cum laude graduate of St. John's University, where he majored in Interpersonal Communication and Political Science, and earned an MBA from Northwestern University Kellogg Graduate School of Management. He is also completing a Doctoral degree in Organizational Leadership from Creighton University.

 

On joining Collagen Solutions, Mr. Ruggiero said: "I was attracted by the Company's mission and the passionate commitment that Jamal and the Board has to grow the business. I believe that Collagen Solutions is well positioned to strengthen and accelerate its core business, while fueling further revenue growth through the sale of its proprietary products."

 

Jamal Rushdy, CEO of Collagen Solutions, added: "I am excited to work with Lou again, having previously worked together at DJO through a period of significant organic and acquired growth. Lou's commercial successes in multiple healthcare and B2B organisations stem from his proven ability to build strong teams, lead with a level of passion, accountability, and creativity, and drive aggressive revenue growth. I have great confidence that Lou's appointment will accelerate our commercial opportunities and look forward to partnering with him to realise our vision to be the industry's first choice for regenerative biomaterials."

 

End

 

 

 

Collagen Solutions PlcJamal Rushdy, Chief Executive OfficerHilary Spence, Chief Financial OfficerLisa Baderoon, Head of Investor Relations

Tel: +44 (0) 141 648 9100Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com

Cenkos Securities plc (NOMAD and Broker)Stephen KeysSteve Cox

Tel: +44 (0) 207 397 8900

Walbrook PRAnna DunphyHelen Cresswell

Tel: +44 (0) 20 7933 8780 or collagen@walbrookpr.comMob: +44 (0) 7876 741 001

 

 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASSIFLUFASELL
Date   Source Headline
6th Nov 202010:08 amRNSHolding(s) in Company
27th Oct 202010:00 amRNSHolding(s) in Company
27th Oct 202010:00 amRNSHolding(s) in Company
23rd Oct 202011:32 amRNSResult of AGM
20th Oct 20205:30 pmRNSCollagen Solutions
20th Oct 20207:03 amRNSCollagen Solutions Acquired by Rosen’s Diversified
20th Oct 20207:03 amRNSRecommended cash offer for Collagen Solutions
20th Oct 20207:03 amRNSDirector/PDMR Shareholding
20th Oct 20207:03 amRNSAllotment of shares to employee benefit trust
20th Oct 20207:00 amRNSOFFER DECLARED UNCONDITIONAL IN ALL RESPECTS
9th Oct 20209:49 amRNSForm 8.5 (EPT/NON-RI)
6th Oct 20207:00 amRNSExtension of Offer and Acceptance Levels
2nd Oct 20208:30 amRNSForm 8.5 (EPT/NON-RI)
29th Sep 20209:36 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
28th Sep 20209:11 amRNSForm 8.5 (EPT/NON-RI)
25th Sep 20201:02 pmRNSNotice of AGM
24th Sep 20208:32 amRNSForm 8.5 (EPT/NON-RI)
23rd Sep 202010:01 amRNSForm 8.5 (EPT/NON-RI)
18th Sep 20209:07 amRNSForm 8.5 (EPT/NON-RI)
17th Sep 20209:42 amRNSForm 8.3 - Collagen Solutions PLC
17th Sep 20208:29 amRNSForm 8.5 (EPT/NON-RI)
15th Sep 20201:04 pmRNSForm 8.3 - Collagen Solutions
15th Sep 20209:19 amRNSForm 8.5 (EPT/NON-RI)
14th Sep 202011:00 amRNSPosting of Offer Document
14th Sep 20209:13 amRNSForm 8.5 (EPT/NON-RI)
11th Sep 20209:20 amRNSForm 8.5 (EPT/NON-RI)
9th Sep 20203:53 pmRNSForm 8.3 - Collagen Solutions
9th Sep 202010:23 amRNSForm 8.5 (EPT/NON-RI)
8th Sep 20209:25 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
7th Sep 20202:19 pmRNSForm 8.3 - Collagen Solutions
7th Sep 20209:40 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
4th Sep 202011:27 amRNSForm 8.3 - Collagen Solutions
3rd Sep 20208:38 amRNSForm 8.5 (EPT/NON-RI)
2nd Sep 20204:30 pmRNSForm 8 (OPD) (Offeror - Rosen's Diversified, Inc.)
2nd Sep 20201:59 pmRNSForm 8.3 - Collagen Solutions
2nd Sep 202011:17 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
2nd Sep 202010:23 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
2nd Sep 20208:26 amRNSForm 8.5 (EPT/NON-RI)
1st Sep 20202:45 pmRNSForm 8.3 - Collagen Solutions plc
1st Sep 202012:48 pmRNSForm 8.3 - Collagen Solutions plc (Amendment)
1st Sep 202010:25 amRNSForm 8.3 - Collagen Solutions plc
1st Sep 20209:38 amRNSForm 8.3 - Collagen Solutions
1st Sep 20209:36 amRNSForm 8.3 - Collagen Solutions
1st Sep 20209:29 amRNSForm 8 (DD) - Collagen Solutions
1st Sep 20207:58 amRNSForm 8.5 (EPT/NON-RI)
28th Aug 20205:25 pmRNSForm 8 (DD) - Collagen Solutions
28th Aug 20203:27 pmRNSDirector/PDMR Shareholding
28th Aug 20201:34 pmGNWForm 8.3 - Collagen Solutions Plc [Amendment]
28th Aug 202010:24 amGNWForm 8.3 - Collagen Solutions Plc
28th Aug 20208:15 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.